Delay discounting decreases in those completing treatment for opioid dependence.
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Several studies examining both control and substance-dependent populations have found delay discounting to remain stable over time. In this report, we examine whether delay discounting changes in opioid-dependent individuals who complete a 12-week treatment. The 159 subjects who completed discounting assessments at baseline and treatment-end come from two separate clinical trials: 56 from Chopra et al. (2009) and 103 from Christensen et al. (2012). Mean discounting at 12 weeks significantly decreased to less than half (44.8%) of the baseline level (95% CIs (27.5, 73.2)). Analyzing each subject's discounting data individually, over 3 times (95% CIs (1.9, 5.5)) as many subjects statistically decreased their discounting from their own baseline levels than those who exhibited a statistical increase. Though we failed to find any relationship among discounting measures and abstinence outcomes, the results from this large study suggest that treatment for substance dependence promotes decreases in delay discounting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls.
Kirby, K. N., Petry, N. M., & Bickel, W. K. (1999) · Journal of Experimental Psychology: General · doi:10.1037/0096-3445.128.1.78 · Cited by 2,171
Self-citationImpulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers
Bickel, W. K., Odum, A. L., & Madden, G. J. (1999) · Psychopharmacology · doi:10.1007/pl00005490 · Cited by 1,433
Self-citationWITHIN‐SUBJECT COMPARISON OF REAL AND HYPOTHETICAL MONEY REWARDS IN DELAY DISCOUNTING
Johnson, M. W., & Bickel, W. K. (2002) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.2002.77-129 · Cited by 991
Self-citationMadden, G. J., Petry, N. M., Badger, G. J., & Bickel, W. K. (1997) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.5.3.256 · Cited by 911
Self-citationRemember the Future: Working Memory Training Decreases Delay Discounting Among Stimulant Addicts
Bickel, W. K., Yi, R., Landes, R. D., Hill, P. F., & Baxter, C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.017 · Cited by 704 · cited 1×
“Coupled with the findings of Bickel et al. (2011), the notion that discounting can change in response to an intervention is strengthened.”
Self-citationDelay discounting of real and hypothetical rewards.
Madden, G. J., Begotka, A. M., Raiff, B. R., & Kastern, L. L. (2003) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.11.2.139 · Cited by 660
Hyperbolic temporal discounting in social drinkers and problem drinkers.
Vuchinich, R. E., & Simpson, C. A. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.6.3.292 · Cited by 624 · cited 1×
“…Petry, & Bickel, 1999; Madden et al., 1999; Madden, Petry, Badger, & Bickel, 1997), cocaine users (Heil, Johnson, Higgins, & Bickel, 2006), methamphetamine users (Hoffman et al., 2006), alcoholics (Vuchinich & Simpson, 1998), and smokers (Bickel, Odum, & Madden, 1999) compared with controls.”
Hariri, A. R., Brown, S. M., Williamson, D. E., Flory, J. D., de Wit, H., & Manuck, S. B. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3446-06.2006 · Cited by 557
One-year temporal stability of delay-discount rates
Kirby, K. N. (2009) · Psychonomic Bulletin & Review · doi:10.3758/pbr.16.3.457 · Cited by 487
Krishnan-Sarin, S., Reynolds, B., Duhig, A. M., Smith, A., Liss, T., McFetridge, A., Cavallo, D. A., Carroll, K. M., & Potenza, M. N. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.09.006 · Cited by 436
Bickel, W. K., Pitcock, J. A., Yi, R., & Angtuaco, E. J. C. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5319-08.2009 · Cited by 278
Self-citationSheffer, C., MacKillop, J., McGeary, J., Landes, R., Carter, L., Yi, R., Jones, B., Christensen, D., Stitzer, M., Jackson, L., et al. (2012) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2012.00224.x · Cited by 263
Self-citationTest–retest reliability of a group-administered paper–pencil measure of delay discounting.
Beck, R. C., & Triplett, M. F. (2009) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0017078 · Cited by 157
Bickel, W. K., Jones, B. A., Landes, R. D., Christensen, D. R., Jackson, L., & Mancino, M. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0021739 · Cited by 66
Self-citation
Cited by
Bickel, W. K., Koffarnus, M. N., Moody, L., & Wilson, A. G. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.013 · Cited by 386
“…and after two clinical trials of a multimodal treatment for opioid dependence and reported in a combined analysis across treatment modality (e.g., various combinations of efficacious treatments including buprenorphine, cognitive behavioral therapy, and contingency management) (Landes et al., 2012).”
BackgroundSelf-citationRung, J. M., & Madden, G. J. (2018) · Journal of Experimental Psychology: General · doi:10.1037/xge0000462 · Cited by 358
Koffarnus, M. N., Jarmolowicz, D. P., Mueller, E. T., & Bickel, W. K. (2013) · Journal of the Experimental Analysis of Behavior · doi:10.1002/jeab.2 · Cited by 308
Self-citationStory, G. W., Vlaev, I., Seymour, B., Darzi, A., & Dolan, R. J. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00076 · Cited by 286
The neurobiology of impulsivity and substance use disorders: implications for treatment
Kozak, K., Lucatch, A. M., Lowe, D. J. E., Balodis, I. M., MacKillop, J., & George, T. P. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13977 · Cited by 281
Metadata
- Authors
- Landes, R. D., Christensen, D. R., & Bickel, W. K.
- Venue
- Experimental and Clinical Psychopharmacology
- Published
- 2012-08
- Volume
- 20
- Issue
- 4
- Pages
- 302-309
- ISSN
- 1064-1297 (ISSN-L)
- 1936-2293
- OpenAlex
- W2005658768
- Cited by
- 87
- References
- 14
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.